Bernd Kammerlander

Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.

Greengate Power Corp. operates as a renewable energy project developer. The firm engages in wind energy development projects. The company was founded by Dan Balaban, Jordan Balaban and Jack Balaban in March 2007 and is headquartered in Calgary, Canada.

Nanosolar, Inc. designs, engineers and manufactures thin film solar cells and panels. It utilizes Print2Power platform that enables higher conversion efficiency and superior thermal stability. The firm offers through its locations in Germany, Switzerland & the United States. The company was founded in May 2002 by Martin R. Roscheisen and Brian Sager and is headquartered in San Jose, CA.

EMBL Ventures GmbH (EMBL Ventures) is a venture investment arm of EMBL which was founded in 2001 by Drs. Stefan Herr, Christoph Antz and Jan Adams to provide start-up companies exploiting EMBL research and intellectual property with equity and expertise to build up and expand their business. Headquartered in Heidelberg, EMBL Ventures manages funds on behalf of institutional and private investors, forming a triad with EMBL (European Molecular Biology Laboratory) and EMBLEM (EMBL Enterprise Management Technology Transfer GmbH) to provide exclusive access to unique technology commercialization opportunities from the EMBL. In addition, their investment activities complement and exploit synergies with EMBL and EMBLEM, providing financial and strategic investors with access to an attractive private equity market and an international scientific and research community, respectively.

Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany.

Barnev, Inc. is a healthcare information technology company specializing in the development, manufacturing, and marketing of comprehensive monitoring and information solutions to clinicians and hospitals for labor and delivery. The firm is the first to market with delivery suite/product solutions that improve the clinical management of patients, and improve economic efficiency for its customers. Its first product, the BirthTrack™ Continuous Labor Monitoring System, is the most exciting innovation in labor progression monitoring since the Friedman Labor Curve was introduced over 50 years ago. The BirthTrack System is a revolutionary continuous labor monitoring technology that provides obstetric caregivers invaluable, precise, objective, real-time information about the physical progress of labor.

zetVisions AG engages in the development and implementation of information technology solutions for legal entity management and master data management. It also develops SAP-based solutions, as well as solutions for different system environments. The company was founded in 2001 and is headquartered in Heidelberg, Germany.

Aster Capital Partners SAS (Aster Capital) is the French venture capital investment subsidiary of Schneider Electric SA (XP: SU), a world-leading electricity management and industrial automation group. Formerly known as Schneider Electric Ventures SAS, the firm was founded by Jean-Marc Bally in 2000 and changed their name to Aster Capital in 2010. Located in Paris with a representative office in China, the firm manages a venture capital fund sponsored by Schneider Electric and cooperates closely with the group's research scientists.

Sensovation AG manufactures and supplies scientific imaging instrumentation products. The firm specializes in the development and production of scientific imaging and low light detection solutions, based on charge coupled device and complementary metal oxide semiconductor technologies. It offers automated digital microscopes, microarray analyzers, and scientific cameras for bioimaging, diagnostics, and quality control in clean technology applications. It also engages in partnerships focused on building and supplying commercial production systems and platforms. The company was founded by Stefan Bickert and Paul Hing in 2000 and is headquartered in Radolfzell, Germany.

Part of Shell Plc, Shell International Exploration & Production BV is an oil and Dutch gas company. The company is based in Rijswijk, Netherlands.

TTTech Computertechnik AG engages in the provision of aerospace, space, manufacturing and energy market solutions. The company was founded by Stefan Poledna and Gerog Kopetz in 1998 and is headquartered in Vienna, Austria.

Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany.

Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA.

Jiff, Inc. provides mobile based consumer-centric software platform for the healthcare industry. It provides an enterprise solution for self-insured employers to connect to and manage digital health tools, and to provide each employee with an individualized health incentives program. The firm’s HIPAA-compliant platform helps companies connect their health benefit design and incentives to the consumer digital health applications, devices, and services that employees know. The company was founded in 2010 by James P. Currier and Stan Chudnovsky and is headquartered in Palo Alto, CA.

Tolomeo Capital AG is the asset management subsidiary of Tolomeo Capital Holding GmbH in Switzerland. Headquartered in Zurich, the firm was founded by Ivan Popovic and Nicolas Mirjoret in 2011 as a spin-off of the quant and risk management unit of one of Switzerland’s largest institutional family offices. Tolomeo Capital is a systematic asset manager which focuses on quantitative, technology-driven investment strategies with a strong emphasis on risk-adjusted returns.

PatientWisdom, Inc. develops and operates platform that collects, curates, segments and shares patient stories. The firm offers services to patients and families, healthcare providers, researchers and educators, and manufacturers and payers. The company was founded by Gregory Makoul and Eric Langshur in 2015 and is headquartered in New Haven, CT.

OGCI Climate Investments LLP (OGCI) is a venture capital arm of OGCI Climate Investments Group Ltd Founded in November 2016. The firm is headquartered in London, United Kingdom with an office in Houston.

Tolomeo Capital Holding GmbH engages in the acquisition of participating interests in firms. It also acquires, manages, and disposes real estate properties. The company was founded on May 31, 2011 and is headquartered in Pfaeffikon, Switzerland.

emPower Health Equity, Inc. provides healthcare services. The company is headquartered in Tiburon, CA.

OrphAI Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in matching drugs to diseases and identifying the care for individual patients using Guardian Angel Artificial Intelligence algorithm. The company was founded by Tian Xu, Jonathan M. Rothberg and Henri S. Lichenstein in 2013 and is headquartered in Guilford, CT.

Inkspace Imaging, Inc. develops magnetic resonance imaging surface receive coils. The company was founded by Ana Claudia Arias, Michael Lustingis and Joseph Corea in 2016 and is headquartered in Pleasanton, CA.

Obersee Bilingual School AG is a private day school located in Wollerau SZ, Switzerland. The school offers a bilingual and future-oriented education for all students. The primary school program provides immersive 50\:50 English-German language learning, with a focus on language and media as a core subject. The school's mission is to provide fair access to learning through OBS+ and enable students to achieve excellence in all aspects of their education. The school also offers the IB Diploma Program and teaches coding and robotics. The school aims to provide students with the skills, resilience, and knowledge they need to shape their own and our future. The school is currently hiring for various positions. The Swiss company was founded in 2003, and the CEOs are Peter Wiki and Uwe R. Feuersenger.

Beyondnetzero (BNZ) is a private equity firm, a subsidiary of General Atlantic LLC founded in 2021 by Lance Darrell Gordon Uggla and Lord John Browne. The firm is headquartered in New York.